نتائج البحث 31-40 من 1900 لعملية البحث عن 핸드폰결제현금Ｒ 【캬툑PP16】【퍼플티켓】 ♣action휴대폰소액결제현금ꎫ휴대폰소액결제현금화핸드폰결제현금ᘂＹ휴대폰결제현금dignified 구글정보이용료현금화ⓥ콘텐츠이용료현금ðⅹnerve
... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...
The purpose of this long term registry study is to collect and analyze information from patients being treated with various forms of radiation therapy to ...
... (R/R) chronic lymphocytic leukemia (CLL). A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers. Rochester, Minn., Scottsdale/Phoenix ...
The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response ...
Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. A Study of ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) on ...
Scottsdale/Phoenix, Ariz. The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
... (R/R) multiple myeloma (MM). Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.